7 Key Takeaways from SCAI 2025
Interested in discovering how the late-breaking science presented at SCAI 2025 will impact your practice?
Read high-level summaries with top takeaways drafted by SCAI experts!
Interested in discovering how the late-breaking science presented at SCAI 2025 will impact your practice?
Read high-level summaries with top takeaways drafted by SCAI experts!
Society for Cardiovascular Angiography & Interventions (SCAI) News
Antiplatelet Therapy and All-Cause Mortality After Transcatheter Aortic Valve Replacement
A retrospective analysis of transaortic valve replacement (TAVR) patients found that single antiplatelet therapy (SAPT) was associated with a significant reduction in all-cause mortality and major bleeding compared to dual antiplatelet therapy (DAPT). The findings support recent guideline updates favoring SAPT as the preferred strategy post-TAVR.
Clinical Outcomes in Stented vs. Non-Stented Chronic Total Occlusion Patients
A large registry analysis showed that patients with chronic total occlusions (CTOs) who received stents with intravascular ultrasound (IVUS) guidance had significantly better clinical outcomes than those treated without stents or without imaging. The findings reinforce the value of IVUS in complex coronary interventions.
Etiology, Management, and Outcomes in SCAI Stage B Cardiogenic Shock
Patients classified as Stage B under the SCAI shock classification system were found to have a 38% in-hospital mortality rate in a large retrospective analysis. The findings highlight the importance of early identification and intervention for this high-risk population.
Insights from the FAVOR III China Trial
Data from the FAVOR III China trial show that using quantitative flow ratio (QFR) to guide percutaneous coronary intervention (PCI) decisions resulted in better outcomes than standard angiography. Patients in the QFR-guided group experienced lower rates of major adverse cardiac events, supporting broader adoption of this strategy in clinical practice.
Ambulatory surgery centers (ASCs) are performing an increasing number of percutaneous coronary interventions (PCIs), with a projected 21% growth over the next decade. The study also found that ASCs disproportionately serve patients from socially vulnerable communities, highlighting their role in expanding access to care.
Prospective Study of a Next-Generation Aventus Thrombectomy System
A prospective study of the Aventus Thrombectomy System demonstrated successful revascularization in nearly all patients with high thrombus burden. The device was associated with a low rate of complications and no distal embolization, suggesting it may be a safe and effective tool for restoring blood flow in complex cases.
A large operator survey found that traditional lead protection is associated with increased orthopedic pain and injury among interventional cardiologists. In contrast, operators using leadless radiation protection systems reported significantly lower rates of musculoskeletal issues, underscoring the long-term benefits of ergonomic alternatives.
About SCAI Scientific Sessions 2025
The SCAI Scientific Sessions annual meeting convenes 2,000 of the world’s premier clinicians, scientists, researchers, and innovators in the field of interventional cardiology and endovascular medicine. With 500+ faculty and hundreds of abstracts, experts in the field work together to share the latest clinical data, procedural guidance, and advanced expertise. Highlights will include live cases, featured clinical research, new SCAI clinical documents, case-based learning, and keynote speakers. For more information, visit SCAI 2025 Scientific Sessions | SCAI.
About Society for Cardiovascular Angiography & Interventions (SCAI)
The Society for Cardiovascular Angiography & Interventions, established in 1978, stands as the primary nonprofit medical society dedicated to representing invasive and interventional cardiology. SCAI's mission is to guide the global interventional cardiovascular community by fostering education, advocacy, research, and upholding standards for quality patient care. For more than 40 years, SCAI has exemplified professional excellence and innovation worldwide, cultivating a reputable community of over 5,000 members committed to advancing medical science and providing life-saving care for individuals, both adults and children, affected by cardiovascular disease. For more information, visit SCAI.ORG.
Find More:
Cardiovascular Ambulatory Surgery Centers (ASCs) Topic Center
The Latest Clinical & Industry News
Grand Rounds With Morton Kern, MD
Peripheral Artery Disease Topic Center
Podcasts: Cath Lab Conversations
